ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DTC Defence Therapeutics Inc

0.36
-0.013 (-3.49%)
03 Dec 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Defence Therapeutics Inc TG:DTC Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.013 -3.49% 0.36 0.36 0.372 0.382 0.36 0.366 29,522 20:59:50

Media advisory: Domtar at the UBS conference

14/09/2006 12:32am

PR Newswire (US)


Defence Therapeutics (TG:DTC)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Defence Therapeutics Charts.
TICKER SYMBOL DTC (TSX, NYSE) MONTREAL, Sept. 13 /PRNewswire-FirstCall/ -- Domtar Inc. announced today that Mr. Raymond Royer, President and Chief Executive Officer and Mr. Daniel Buron, Senior Vice President and Chief Financial Officer will make a presentation at the UBS Conference in New York on Tuesday, September 19, 2006 at 3:30 p.m. (EDT). Financial analysts, media and other interested individuals are invited to listen to the live broadcast on the Domtar corporate website at http://www.domtar.com/en/investors/media/index.asp. DOMTAR IS THE THIRD LARGEST PRODUCER OF UNCOATED FREESHEET PAPER IN NORTH AMERICA. IT IS ALSO A LEADING MANUFACTURER OF BUSINESS PAPERS, COMMERCIAL PRINTING AND PUBLICATION PAPERS, AND TECHNICAL AND SPECIALTY PAPERS. DOMTAR MANAGES ACCORDING TO INTERNATIONALLY RECOGNIZED STANDARDS 18 MILLION ACRES OF FORESTLAND IN CANADA AND THE UNITED STATES, AND PRODUCES LUMBER AND OTHER WOOD PRODUCTS. DOMTAR HAS 9,800 EMPLOYEES ACROSS NORTH AMERICA. THE COMPANY ALSO HAS A 50% INVESTMENT INTEREST IN NORAMPAC INC., THE LARGEST CANADIAN PRODUCER OF CONTAINERBOARD. DATASOURCE: DOMTAR INC. CONTACT: Investor relations: Pascal Bosse, Manager, Investor relations, (514) 848-5938, ; Source: Daniel Buron, Senior Vice President and Chief Financial Officer, (514) 848-5234,

Copyright

1 Year Defence Therapeutics Chart

1 Year Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

Your Recent History

Delayed Upgrade Clock